Related Experiment Video

Updated: May 16, 2026

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)
04:56

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)

Published on: August 4, 2023

Increased procoagulant function of microparticles in pediatric inflammatory bowel disease: role in increased thrombin

Andrea Deutschmann1, Axel Schlagenhauf, Bettina Leschnik

  • 1Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Auenbruggerplatz 34/2, Graz, Austria.

Journal of Pediatric Gastroenterology and Nutrition
|November 21, 2012
PubMed

Insights

Circulating microparticles show increased procoagulant activity in pediatric inflammatory bowel disease (IBD) patients. However, these microparticles are not the primary driver of heightened thrombin generation in IBD.

Area of Science:

  • Hematology
  • Pediatric Gastroenterology
  • Thrombosis Research

Background:

  • Patients with inflammatory bowel disease (IBD) exhibit an elevated risk of venous thromboembolism (VTE) compared to the general population.
  • The underlying mechanisms contributing to thrombotic events in IBD remain incompletely elucidated.
  • Understanding these mechanisms is crucial for developing targeted preventative and therapeutic strategies.

Purpose of the Study:

  • To investigate the levels and procoagulant activity of circulating microparticles in pediatric patients with IBD.
  • To assess the influence of these microparticles on thrombin generation during active and quiescent disease states.
  • To compare these findings with those of healthy pediatric controls.

Main Methods:

  • Plasma samples were analyzed from 33 pediatric patients with Crohn disease (CD), 20 with ulcerative colitis (UC), and 60 healthy controls.
  • Microparticle procoagulant activity was quantified using enzyme-linked immunosorbent assay (ELISA).
  • Calibrated automated thrombography (CAT) determined the dependence of thrombin generation on microparticle-derived tissue factor.

Main Results:

  • Significantly increased microparticle procoagulant function was observed in patients with active and inactive CD, and active UC, relative to controls.
  • Endogenous thrombin potential was markedly higher in pediatric patients with CD and UC compared to healthy individuals.
  • Microparticles exerted only a minor influence on thrombin generation, specifically in patients with active UC.

Conclusions:

  • Pediatric IBD patients, particularly those with active disease, demonstrate heightened procoagulant activity of circulating microparticles.
  • Despite increased procoagulant function, microparticles do not appear to be the predominant factor driving elevated thrombin generation in pediatric IBD.
  • Further research is warranted to fully elucidate the complex thrombotic pathways in pediatric IBD.
Abstract

More Related Videos

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...